Cambium Biomaterials Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
205
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$101M
- Investors
-
24
Cambium Biomaterials General Information
Description
Developer of an advanced materials platform designed to accelerate the discovery, development, and scale of next-generation high-performance materials. The company offers an AI-driven materials platform integrated with chemistry, materials science, biology, and composite manufacturing, enabling aerospace, automotive, and other high-performance manufacturing sectors to move efficiently from material discovery to certified, high-volume production.
Contact Information
Website
cambiumglobal.comCorporate Office
- 111 Maryland Street
- El Segundo, CA 90245
- United States
Corporate Office
- 111 Maryland Street
- El Segundo, CA 90245
- United States
Cambium Biomaterials Timeline
Cambium Biomaterials Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series B) | 05-Jan-2026 | $101M | Completed | Generating Revenue | ||
| 4. Later Stage VC (Series A1) | 14-Aug-2025 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 08-Nov-2023 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 02-Sep-2021 | $8.01M | $11M | Completed | Startup | |
| 1. Seed Round | $3M | $3M | Completed | Startup |
Cambium Biomaterials Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B-1 | ||||||||
| Series B | ||||||||
| Series A-3 | ||||||||
| Series A-2 | ||||||||
| Series A-1 | ||||||||
| Series A | 30,417,553 | $0.000010 | $0.2 | $0.2 | 1x | $0.2 | 3.97% | |
| Seed | 36,452,005 | $0.000010 | $0.08 | $0.08 | 1x | $0.08 | 4.75% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Cambium Biomaterials Comparisons
Industry
Financing
Details
Cambium Biomaterials Competitors (7)
One of Cambium Biomaterials’s 7 competitors is Hexcel, a Corporation company based in Stamford, CT.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Hexcel | Corporation | Stamford, CT | ||||
| Tex Tech Industries | Formerly PE-Backed | Kernersville, NC | ||||
| Karman Holdings | Formerly PE-Backed | Huntington Beach, CA | ||||
| Park Aerospace | Corporation | New York, NY | ||||
| Toray Industries | Corporation | Tokyo, Japan |
Cambium Biomaterials Patents
Cambium Biomaterials Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026236462-A1 | Phthalonitrile and polyimide-based compositions | Pending | 07-May-2025 | ||
| US-20260242618-A1 | Polymer foam comprising phthalonitrile-based resins and carboxylate-containing blowing agents and methods of preparing same | Pending | 14-Feb-2025 | ||
| WO-2026174264-A1 | Polymer foam comprising phthalonitrile-based resins and carboxylate-containing blowing agents and methods of preparing same | Pending | 14-Feb-2025 | ||
| WO-2026174266-A1 | Polymer foam comprising phthalonitrile-based resins and carboxylate-containing blowing agents and methods of preparing same | Pending | 14-Feb-2025 | ||
| WO-2025179261-A1 | Phthalonitrile-based precursors, high-temperature resin, and composite compositions thereof | Pending | 23-Feb-2024 | C08G65/38 |
Cambium Biomaterials Signals
Cambium Biomaterials Investors (24)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alumni Ventures | Venture Capital | Minority | ||
| Inevitable Ventures | Venture Capital | Minority | ||
| J17 Ventures | PE/Buyout | Minority | ||
| JACS Capital Partners | Venture Capital | Minority | ||
| Mañana Investments | Venture Capital | Minority |
Cambium Biomaterials Acquisitions (1)
Cambium Biomaterials’s most recent deal was a Merger/Acquisition with SHD Composites. The deal was made on 02-Dec-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| SHD Composites | 02-Dec-2025 | Merger/Acquisition | Industrial Supplies and Parts |
Cambium Biomaterials Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| SHD Composites | Sleaford, United Kingdom | 2010 |
Cambium Biomaterials FAQs
-
When was Cambium Biomaterials founded?
Cambium Biomaterials was founded in 2019.
-
Where is Cambium Biomaterials headquartered?
Cambium Biomaterials is headquartered in El Segundo, CA.
-
What is the size of Cambium Biomaterials?
Cambium Biomaterials has 205 total employees.
-
What industry is Cambium Biomaterials in?
Cambium Biomaterials’s primary industry is Aerospace and Defense.
-
Is Cambium Biomaterials a private or public company?
Cambium Biomaterials is a Private company.
-
What is the current valuation of Cambium Biomaterials?
The current valuation of Cambium Biomaterials is .
-
What is Cambium Biomaterials’s current revenue?
The current revenue for Cambium Biomaterials is .
-
How much funding has Cambium Biomaterials raised over time?
Cambium Biomaterials has raised $142M.
-
Who are Cambium Biomaterials’s investors?
Alumni Ventures, Inevitable Ventures, J17 Ventures, JACS Capital Partners, and Mañana Investments are 5 of 24 investors who have invested in Cambium Biomaterials.
-
Who are Cambium Biomaterials’s competitors?
Hexcel, Tex Tech Industries, Karman Holdings, Park Aerospace, and Toray Industries are some of the 7 competitors of Cambium Biomaterials.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process